Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects
Clinical trial NCT01375764 · COMPLETED
Trial details
- NCT number
- NCT01375764
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-28
- Primary completion
- 2012-05-08
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.